pro-diazepam has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bird, M; Docx, CJ; Fairhall, SJ; Flint, DP; Green, AC; Poole, SJC; Price, ME; Rice, H; Tattersall, JEH; Timperley, CM; Whiley, L | 1 |
| Armstrong, S; Mumford, H; Price, M; Scott, L; Wetherell, J | 1 |
2 other study(ies) available for pro-diazepam and Disease Models, Animal
| Article | Year |
|---|---|
Pharmacokinetic profile and quantitation of protection against soman poisoning by the antinicotinic compound MB327 in the guinea-pig.
Topics: Animals; Anticonvulsants; Antidotes; Atropine; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Guinea Pigs; Lethal Dose 50; Male; Muscarinic Antagonists; Nerve Agents; Nicotinic Antagonists; Poisoning; Pyridinium Compounds; Soman | 2016 |
Development of next generation medical countermeasures to nerve agent poisoning.
Topics: Animals; Antidotes; Atropine; Chemical Warfare Agents; Dipeptides; Disease Models, Animal; Drug Therapy, Combination; Guinea Pigs; Ileal Diseases; Intussusception; Lethal Dose 50; Male; Neurotoxicity Syndromes; Oximes; Physostigmine; Pyridinium Compounds; Scopolamine Derivatives; Soman; Time Factors | 2007 |